Christopher Hayes joined Athyrium in 2023, where he currently serves as an associate covering healthcare products and healthcare services & technology.

Prior to joining Athyrium, Chris was an Investment Banking Analyst in the Healthcare group at Lazard from 2021-2023. Before Lazard, he was an Investment Banking Analyst in the M&A group at Cowen.

Chris graduated from the University of Notre Dame in 2020 with a B.B.A. in Finance and a minor in History.